Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12038781rdf:typepubmed:Citationlld:pubmed
pubmed-article:12038781lifeskim:mentionsumls-concept:C2717961lld:lifeskim
pubmed-article:12038781lifeskim:mentionsumls-concept:C0032176lld:lifeskim
pubmed-article:12038781lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:12038781lifeskim:mentionsumls-concept:C1457869lld:lifeskim
pubmed-article:12038781lifeskim:mentionsumls-concept:C0205217lld:lifeskim
pubmed-article:12038781lifeskim:mentionsumls-concept:C2263455lld:lifeskim
pubmed-article:12038781lifeskim:mentionsumls-concept:C0205197lld:lifeskim
pubmed-article:12038781pubmed:issue5lld:pubmed
pubmed-article:12038781pubmed:dateCreated2002-5-31lld:pubmed
pubmed-article:12038781pubmed:abstractTextVon Willebrand factor (vWF) cleaving metalloprotease activity represents an important factor in understanding the pathophysiology of thrombotic microangiopathies (TMA). Thrombotic events, leading to dramatic complications, occur preferentially in the microvasculature. Our aim was to determine the ability of TMA plasma with a complete deficiency of protease activity to promote shear-induced platelet aggregation (SIPA) at high shear rates using a coaxial cylinder shearing device. We have demonstrated the ability of four out of seven TMA plasma to aggregate normal washed platelets at 4,000 s(-1). In these four TMA plasma, significant SIPA was obtained, whereas control plasma did not induce more SIPA than buffer. The % of unusually large (UL) multimers in TMA plasma varied from 1 to 18%. Surprisingly, the extent of SIPA in TMA plasma appeared independent of the percentage of UL multimers. Interestingly, anti-GPIb antibody 6D1 could block completely this pathological aggregation, opening new therapeutic possibilities. In contrast, none of eight other TMA patients' plasma with a normal protease activity, exhibited any increase of SIPA compared with control plasma. These results strongly suggest that the deficiency of vWF-cleaving protease appears to be necessary, but not sufficient for elevated SIPA. In contrast, the % of UL is not associated with increased SIPA.lld:pubmed
pubmed-article:12038781pubmed:languageenglld:pubmed
pubmed-article:12038781pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12038781pubmed:citationSubsetIMlld:pubmed
pubmed-article:12038781pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12038781pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12038781pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12038781pubmed:statusMEDLINElld:pubmed
pubmed-article:12038781pubmed:monthMaylld:pubmed
pubmed-article:12038781pubmed:issn0340-6245lld:pubmed
pubmed-article:12038781pubmed:authorpubmed-author:DenisCécile...lld:pubmed
pubmed-article:12038781pubmed:authorpubmed-author:MeyerDominiqu...lld:pubmed
pubmed-article:12038781pubmed:authorpubmed-author:BaruchDominiq...lld:pubmed
pubmed-article:12038781pubmed:authorpubmed-author:AjzenbergNadi...lld:pubmed
pubmed-article:12038781pubmed:authorpubmed-author:VeyradierAgnè...lld:pubmed
pubmed-article:12038781pubmed:authorpubmed-author:GirmaJean-Pie...lld:pubmed
pubmed-article:12038781pubmed:issnTypePrintlld:pubmed
pubmed-article:12038781pubmed:volume87lld:pubmed
pubmed-article:12038781pubmed:ownerNLMlld:pubmed
pubmed-article:12038781pubmed:authorsCompleteYlld:pubmed
pubmed-article:12038781pubmed:pagination808-11lld:pubmed
pubmed-article:12038781pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:12038781pubmed:meshHeadingpubmed-meshheading:12038781...lld:pubmed
pubmed-article:12038781pubmed:meshHeadingpubmed-meshheading:12038781...lld:pubmed
pubmed-article:12038781pubmed:meshHeadingpubmed-meshheading:12038781...lld:pubmed
pubmed-article:12038781pubmed:meshHeadingpubmed-meshheading:12038781...lld:pubmed
pubmed-article:12038781pubmed:meshHeadingpubmed-meshheading:12038781...lld:pubmed
pubmed-article:12038781pubmed:meshHeadingpubmed-meshheading:12038781...lld:pubmed
pubmed-article:12038781pubmed:meshHeadingpubmed-meshheading:12038781...lld:pubmed
pubmed-article:12038781pubmed:meshHeadingpubmed-meshheading:12038781...lld:pubmed
pubmed-article:12038781pubmed:meshHeadingpubmed-meshheading:12038781...lld:pubmed
pubmed-article:12038781pubmed:meshHeadingpubmed-meshheading:12038781...lld:pubmed
pubmed-article:12038781pubmed:meshHeadingpubmed-meshheading:12038781...lld:pubmed
pubmed-article:12038781pubmed:meshHeadingpubmed-meshheading:12038781...lld:pubmed
pubmed-article:12038781pubmed:meshHeadingpubmed-meshheading:12038781...lld:pubmed
pubmed-article:12038781pubmed:meshHeadingpubmed-meshheading:12038781...lld:pubmed
pubmed-article:12038781pubmed:year2002lld:pubmed
pubmed-article:12038781pubmed:articleTitleComplete defect in vWF-cleaving protease activity associated with increased shear-induced platelet aggregation in thrombotic microangiopathy.lld:pubmed
pubmed-article:12038781pubmed:affiliationINSERM U143, Hôpital de Bicêtre, Paris, France.lld:pubmed
pubmed-article:12038781pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12038781pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:11093entrezgene:pubmedpubmed-article:12038781lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12038781lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12038781lld:pubmed